Implantica will begin commercializing RefluxStop in Spain and Italy

"Implantica AG (publ) today announces that the company will start commercializing RefluxStop™ on a reimbursed basis in Italy and Spain based on local/regional hospital agreements."

"Implantica will now focus on providing RefluxStop™ to the leading anti-reflux surgeons and centers in Italy and Spain. Surgical training will commence initially via webinar with representatives from Germany and Switzerland until Covid-19 subsides..."

021521 Implantica makes headway in Italy

.

Download • 76KB